These InformationWeek 500 innovators are trying
unique approaches to solve business problems. Could
your company use a few extra bright ideas?
5 of 20
In developing new drugs, Eli Lilly devotes significant time to drug and disease modeling. Before its Modeling and Simulation Explorer effort, referred to as MuSE, generating and packaging simulation results was a manual process that took a significant amount of modeling experts' time.
MuSE created an interactive environment that makes it possible to extract and visualize model-derived information in real time. This information makes it easier to pick drug compounds and doses, as well as to optimize study designs.
Executing simulations and compiling results, which previously required days or weeks of modeling experts' time, can now be done in minutes. And Lilly clinical trial designs are benefiting from improved dose/response relationships, better trial dose starting points, and the ability to simulate multiple trial endpoints. All of these contribute to more efficient clinical trials with fewer failed designs.
5 Top Federal Initiatives For 2015As InformationWeek Government readers were busy firming up their fiscal year 2015 budgets, we asked them to rate more than 30 IT initiatives in terms of importance and current leadership focus. No surprise, among more than 30 options, security is No. 1. After that, things get less predictable.
Join us for a roundup of the top stories on InformationWeek.com for the week of December 14, 2014. Be here for the show and for the incredible Friday Afternoon Conversation that runs beside the program.